United Kingdom· GB-APID-38704511000001108
Veyvondi 1,300unit powder and solvent for solution for injection vials
A vonicog alfa product containing vonicog alfa, registered in United Kingdom by Takeda UK Ltd. The same ATC class is registered in 2 of our 19 countries.
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
Where it is registered
Vonicog alfa is registered in 2 of 19 countries.
Countries holding a registration under ATC B02BD40 (vonicog alfa), each read from that country’s own register.
- This record: United Kingdom, from NHS dm+d (United Kingdom)
- 1 of them publish a price we can compare per daily dose
Vonicog alfa · ATC B02BD40
2 / 19 countries
- Franceprice
- United Kingdom
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Vonicog alfa
- Manufacturer
- Takeda UK Ltd
- Country
- United Kingdom (GB)
- ATC code
- B02BD40
- ATC class
- Vonicog alfa
- Defined daily dose
- 1.5 TSD, E
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- September 13, 2026
Packs & prices · 1
- gtin00642621070552
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Vonicog alfa in 12 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenVEYVONDI 1300 IE Pulver och vätska till injektionsvätska, lösningBaxalta Innovations GmbH
- SwitzerlandVEYVONDI 1300 IE, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungTakeda Pharma AG
- CzechiaVEYVONDIBaxalta Innovations GmbH, Vídeň
- FinlandVeyvondiBaxalta Innovations GmbH
- FranceVEYVONDI 1 300 UI poudre et solvant pour solution injectableBAXALTA INNOVATIONS (AUTRICHE)
- PolandVEYVONDIBaxalta Innovations GmbH
- BelgiumVeyvondi 1300 IUBaxalta Innovations
- IrelandVEYVONDI 1300 IU powder and solvent for solution for injectionBaxalta Innovations GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Veyvondi
- Liechtenstein · Veyvondi
- Norway · Veyvondi
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/98acc436-f889-4ebf-90e0-43aa59b615b6 GET /v1/drugs/98acc436-f889-4ebf-90e0-43aa59b615b6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "38704511000001108",
"desc": "Veyvondi 1,300unit powder and solvent for solution for injection vials (Takeda UK Ltd)",
"form": "Powder and solvent for solution for injection",
"vpid": "38727711000001103",
"source": "dmd",
"vtm_id": "38721211000001100",
"strength": "1300 unit",
"substance": "Vonicog alfa",
"ingredient": "Vonicog alfa",
"supplier_code": "3811601000001107"
}See everything about vonicog alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.